Uncategorized

How sponsors can meet the FDA’s diversity action plan requirements New FDA guidelines are reshaping diversity in clinical trials. Download […]

Faced with the rapidly growing litigation, the U.S. Judicial Panel on Multidistrict Litigation (JPML) established a Bard PowerPort lawsuit MDL

The dynamic nature of the biotech industry requires operational flexibility in clinical development. One primary way biotech achieves this adaptive

Simon Cote has over 22 years of experience in the pharmaceutical industry with a focus in drug product development and

Judge Rowland has scheduled a status conference for today, at which time the parties are expected to update the Court

Designing nanodevices that can change shape and function in response to molecular signals is a key objective in protein design,

Several recent developments have caused many people in our industry to think differently about affordability and access. In July, GoodRx and Boehringer

Castillo indicates in the lawsuit that he worked in Los Angeles as a stone countertop fabricator and installer from 2000

Virtual agents: The future of pharma education, engagement and insights This exclusive whitepaper dives into the cutting-edge applications of virtual

Join us for an eye-opening conversation with Eric Solomon, Practice Leader for Paid Media activation at AI-industry innovator at Real